Products
Genetic testing of inherited diseases in newborn

The case of genetic testing:

The first case of the third generation in vitro fertilized infant in China was born in Shanghai via single-cell high-throughput sequencing technique. The infant’s father was a patient with thyroid carcinoma and there is 50% chance to pass his pathogenic gene to the next generation. The medical specialists blocked out the opportunity of spreading of the familial thyroid cancers through genetic screeing and sequencing techniques.

In order to monitor the corresponding pathogenic gene mutations of common genetic disease of the newborn, to comprehensive interpret high risk genetic loci that have been reported, generation of the first " genetic profile” for your precious baby will be our first priority at your service.

about us
about us

Jiuzhou Genetics focuses on the application of high-throughput sequencing and other cutting-edge biotechnologies in human medical and healthcare fields. We concentrate on the field of personal genomics, aiming to provide the best professional services on genetic counseling for Chinese, molecular diagnosis of the highest quality and the world-leading precise individualized treatment regimens as high-end services to our clients. This company was established in September of 2016 and registered in the central Science & Technology Park of Shijingshan region in Beijing.